Orchid Pharma Q4FY21 consolidated loss at Rs. 24.72 Cr
Chemical

Orchid Pharma Q4FY21 consolidated loss at Rs. 24.72 Cr

The company reported total income of Rs.455.28 crores during the 12 months period ended March 31, 2021

  • By ICN Bureau | May 23, 2021

Orchid Pharma has reported total income of Rs.130.84 crores during the period ended March 31, 2021 as compared to Rs.104.52 crores during the period ended December 31, 2020. The company reported total income of Rs.92.77 crores during the period ended March 31, 2020.

Orchid Pharma has posted net loss of Rs. (24.72) crores for the period ended March 31, 2021 as against net loss of Rs.(44.72) crores for the period ended December 31, 2020.The company posted net loss of Rs.(38.85) crores for the period ended March 31, 2020.

The company has reported total income of Rs.455.28 crores during the 12 months period ended March 31, 2021 as compared to Rs.508.07 crores during the 12 months period ended March 31, 2020.

The company has posted net loss of Rs.(116.53) crores for the 12 months period ended March 31, 2021 as against net loss of Rs.(131.07) crores for the 12 months period ended March 31, 2020.

Upcoming Conferences

Agrochem Summit 2025

November 19, 2025

PetroChem Summit 2025

December 17, 2025

Other Related stories

Startups

Petrochemical

Energy

Digitization